Kaempferol

Kaempferol

SCHEMBL18817

O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 1.00
KMT2A Q03164 9/20 1.00
CYP1A2 P05177 8/20 1.00
CYP3A4 P08684 8/20 1.00
ABCB1 P08183 7/20 1.00
CYP2C9 P11712 7/20 1.00
CYP1A1 P04798 7/20 1.00
CYP1B1 Q16678 7/20 1.00
KDM4E B2RXH2 7/20 1.00
FTO Q9C0B1 6/20 1.00
XDH P47989 6/20 1.00
MAPT P10636 6/20 1.00
HSD17B10 Q99714 6/20 1.00
CYP2D6 P10635 6/20 1.00
ALOX15 P16050 5/20 1.00
CYP2C19 P33261 5/20 1.00
APP P05067 5/20 1.00
TP53 P04637 5/20 1.00
ALDH1A1 P00352 5/20 1.00
HPGD P15428 5/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kaempferol SCHEMBL1259228 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL29378805 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL30655455 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL34461912 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31256029 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL30544809 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31749037 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31577746 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL17237761 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL38651062 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 31492 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075560-A Application of total flavonoids of sea buckthorn leaves in preparing medicines for treating ulcerative colitis 2026-05-26 CN claimed
CN-122080093-A Compounds effective in treating liver toxicity and fatty liver disease and uses thereof 2026-05-26 CN claimed
US-12636281-B2 Dietary supplements to ameliorate dietary inadequacies related to brain health or neurodegenerative diseases, and methods to design dietary supplements NEURORESERVE INC. (US) 2026-05-26 US claimed
CN-118845751-B Application of kaempferide and/or kaempferide metabolite in preparation of antiviral infection medicine SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE (CN) 2026-05-26 CN claimed
WO-2026107510-A1 HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION BIOBOND ADHESIVES, INC. (US) 2026-05-21 WO claimed
EP-4378448-B1 EXTRACT OF FLOWERS, LEAVES AND/OR SEED PODS OF IMPATIENS AND LEAVES OF PANDANUS, IN DRIED AND LIQUID FORM, A METHOD OF ITS OBTAINING AND USE THEREOF PBCLABS SP Z O O (PL) 2026-05-20 EP claimed
EP-4743181-A1 POLYPHENOL-RICH DAMASK ROSE EXTRACT DERIVED FROM A HYDRODISTILLATION BYPRODUCT AND ITS USES AS A FOOD SUPPLEMENT Robertet S.A. (FR) 2026-05-20 EP claimed
EP-4742915-A1 LOW-FAT PLANT MEALS CONTAINING AGGREGATED PLANT GLOBULINS, PLANT-GLOBULIN-ENRICHED PRODUCTS, AND RELATED PROCESSES Napiferyn Biotech Sp. Z O.o (PL) 2026-05-20 EP claimed
CN-122056926-A Probiotic composition containing melatonin and application of composition in sleep 南京北极光生物科技有限公司 2026-05-19 CN claimed
CN-122063206-A Method for verifying uric acid reducing action mechanism of apocynum venetum leaf extract 山东航空学院 2026-05-19 CN claimed
EP-0206219-B1 PHOTOSTABILISING OF SYDNONIMINES CASSELLA Aktiengesellschaft (DE) 1989-09-06 EP claimed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP claimed
US-4774229-A ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT CHEMEX PHARMACEUTICALS, INC. (US) 1988-09-27 US claimed
EP-0275005-A2 Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them INDENA S.p.A. (IT) 1988-07-20 EP claimed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO claimed
EP-0257887-A2 Ophthalmic compositions HOUSTON BIOTECHNOLOGY INCORPORATED (US) 1988-03-02 EP claimed
EP-0245931-A2 Nodulation inducing factors LUBRIZOL GENETICS INC. (US) 1987-11-19 EP claimed
WO-1987006833-A1 MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE CHEMEX PHARMACEUTICALS, INC. (US) 1987-11-19 WO claimed
EP-0206219-A1 Photostabilising of sydnonimines CASSELLA Aktiengesellschaft (DE) 1986-12-30 EP claimed
US-4617293-A Flavonoid phosphate salts of aminoglycoside antibiotics MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1986-10-14 US claimed